ROCHE HOLDING LTD (RHHBY)
Clinical trial NCT05386576 updates: 1. completion date: 2026-05-01 → 2027-05-01 2. primary completion date: 2026-05-01 → 2027-05-01
Clinical trial NCT05386576 updates: 1. completion date: 2026-05-01 → 2027-05-01 2. primary completion date: 2026-05-01 → 2027-05-01
Clinical trial NCT06673043 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 100 → 105 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05624931 updates: 1. enrollment: 108 → 118 participants 2. masking: DOUBLE → NONE
Clinical trial NCT07607483 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-06-03
Clinical trial NCT04715685 updates: 1. completion date: 2026-05-31 → 2026-11-30 2. primary completion date: 2026-05-01 → 2026-11-01
Clinical trial NCT06472076 updates: 1. completion date: 2027-02-02 → 2027-08-30 2. primary completion date: 2027-02-02 → 2026-06-30
Clinical trial NCT06615635 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2025-12-01 → 2026-01-01 3. primary completion date: 2025-12-01 → 2026-12-01
Clinical trial NCT06873789 updates: 1. completion date: 2026-05-08 → 2026-07-30 2. primary completion date: 2026-05-08 → 2026-07-30
Clinical trial NCT06551519 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 700 → 489 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07564401: start date: 2026-05-14 → 2026-06-30.